Misplaced Pages

Draft:Bias Capital

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Brandon (talk | contribs) at 00:32, 17 December 2024 (Nominated for deletion; see Misplaced Pages:Articles for deletion/Bias Capital.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 00:32, 17 December 2024 by Brandon (talk | contribs) (Nominated for deletion; see Misplaced Pages:Articles for deletion/Bias Capital.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This template is being used in the wrong namespace. To nominate this talk page for deletion, go to Miscellany for deletion.

An editor has nominated this article for deletion.
You are welcome to participate in the deletion discussion, which will decide whether or not to retain it.Feel free to improve the article, but do not remove this notice before the discussion is closed. For more information, see the guide to deletion.
Find sources: "Bias Capital" – news · newspapers · books · scholar · JSTOR%5B%5BWikipedia%3AArticles+for+deletion%2FBias+Capital%5D%5DAFD
Bias Capital
Company typePrivate
IndustryVenture capital
FoundedFebruary 2021; 3 years ago (2021-02)
FounderMaximillian Naza
HeadquartersSan Francisco, California, U.S.
ProductsInvestments
Websitehttps://bias.capital/

Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering accredited investors and qualified purchasers the opportunity to access and participate in select investment opportunities.

Bias Capital operates as the venture capital arm of PasciVite.

Notable Investments

In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.

Other notable investments include Grabango, Wayflyer, Fintor, Valtivis, Flower CO. and FLYR.

References

  1. "Bias Capital". web.archive.org. 2021-10-06. Retrieved 2024-12-16.
  2. "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.
  3. "Bias Capital Investment Portfolio | PitchBook". pitchbook.com. Retrieved 2024-12-16.
Categories: